FHA
GTHX

First Horizon Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

First Horizon Advisors’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13
Closed – – 2474
2021
Q3 		$0 Buy
+13
New +$212 ﹤0.01% 2455

Other funds holding GTHX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

First Horizon Advisors's GTHX Position: Q4 2021 in Review

First Horizon Advisors sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2021, closing a stake of 13 shares.

First Horizon Advisors first reported a position in GTHX in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 108 funds tracked by Wall St. Rank hold GTHX as of Q4 2021.

  • First Horizon Advisors reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • First Horizon Advisors sold 13 G1 Therapeutics, Inc. Common Stock shares in Q4 2021.
  • First Horizon Advisors first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • First Horizon Advisors's G1 Therapeutics, Inc. Common Stock position peaked at $0 in Q3 2021.
  • 108 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2021.

Based on First Horizon Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.